FerroKin Biosciences

About:

Ferrokin Biosciences develops and markets medical devices such as Iron Chelator for the treatment of iron-overload in patients.

Top Investors: MP Healthcare Venture Management, Celgene, HealthCap, Clarus Ventures, Burrill & Company

Description:

Ferrokin Biosciences Inc. develops and markets medical devices. The company offers iron chelator for the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemias. The company is based in San Carlos, California.

Total Funding Amount:

$30M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2007-01-01

Founders:

Hugh Rienhoff

Number of Employees:

1-10

Last Funding Date:

2012-02-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai